Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes
Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed
Dr Kevin Fernando explains how SIGN 154 offers evidence-based guidance on glucose control therapies for people with type 2 diabetes
Dr Kevin Fernando provides top tips on diagnosing and managing type 2 diabetes and identifying people at high risk
Dr Dinesh Nagi provides insight into an integrated model of care provided by primary care and specialist diabetes teams
Test and reflect
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide.
The development of this Guidelines video has been supported by an educational grant from Napp Pharmaceuticals Limited. Napp Pharmaceuticals Limited had no influence over the selection of the speaker or the content of the video, and checked the final files for technical accuracy only.
Related Guidelines summaries
Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment.
What are the signs of pancreatic exocrine insufficiency in diabetes? This concise management algorithm covers symptoms, investigations, and referral.
This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm
Find out in this summary when HbA1c should not be used as a sole test to diagnose diabetes. Includes an algorithm for diagnosis and treatment.